New product: Skyrizi (risankizumab) 150 mg solution for injection in pre-filled syringe
Risankizumab is a humanised indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy.
Source:
electronic Medicines compendium